The results are in for the first-ever randomized clinical trial on UVC disinfection. The Benefits of Enhanced Terminal Room Disinfection (BETR-D) study was funded by the Centers for Disease Control and Prevention (CDC) and conducted across nine hospitals in the Duke Infection Control Outreach Network (DICON) from 2012-2014.
This secondary analysis of the BETR-D study shows that with an enhanced terminal room UV disinfection program in place, the entire hospital environment is safer. Regardless of whether the room was previously occupied with a patient who had an MDRO (multidrug-resistant organism), or whether or not they had been previously colonized, if you add a structured, targeted UV disinfection program to your cleaning protocols and a high compliance of manual cleaning, your hospital will likely have fewer incidences of C. diff and VRE.
A new sub study shows that enhanced terminal room disinfection with Tru-D SmartUVC can lead to a decrease in the incidence of targeted multidrug-resistant organisms such as C. diff and VRE for all patients, hospital-wide when used with 93% compliance with standard disinfection protocols. (Individual hospital results may vary.) The study was recently published in The Lancet Infectious Diseases and discusses the prescribed secondary analysis of the BETR-D randomized clinical trial.
Leading researchers in infection prevention and control wanted to conduct a randomized clinical trial that would determine the efficacy, effectiveness and feasibility of enhanced terminal room disinfection to prevent hospital-acquired infections.
In addition to the BETR-D study, researchers have completed twenty, independent, third-party studies on Tru-D that all demonstrate its effectiveness.
Several studies conducted contemporaneously with the BETR-D are expected to be published over time. The first such paper was recently published in Infection Control and Hospital Epidemiology and outlines the implementation process for Tru-D in the BETR-D study.
Two 5-foot-5 UVC disinfection robots have been deployed to JFK Hospital and ELWA Hospital in Monrovia, Republic of Liberia.